Stock 1177 SINO BIOPHARMACEUTICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-05-31 am EDT 		5-day change 1st Jan Change
2.84 HKD +1.43% Intraday chart for Sino Biopharmaceutical Limited -1.05% -18.16%
May. 24 Sino Biopharmaceutical's Renal Cancer Combination Treatment Shows Promise in Phase III Trials MT
May. 23 Sino Biopharmaceutical Limited Announces Positive Results on Phase III Study of Benmelstobart Injection in Combination with Anlotinib Hydrochloride Capsules for First-Line Treatment of Advanced Renal Cell Carcinoma CI

Evolution of the average Target Price on Sino Biopharmaceutical Limited

Price target over the last 5 years

History of analyst recommendation changes

d3c1c2444803b9eac25f4310c4a.WnOIwIwAtRBBvmnRYLsUysCzuBFgiz5UFsRm8EzScIg.Ygr5rsFo2HgU_wrpAolnhrr1jlNYs2hlL6sruH2aPbkvMvGw4U3_WQ7nBg~afc5ee19e5ebacd284d4297de329ccea

Analyst Recommendations on Sino Biopharmaceutical Limited

Nomura Adjusts Sino Biopharmaceutical’s Price Target to HK$6.16 From HK$6.63, Keeps at Buy MT
Sino Biopharmaceutical Gets 'A' ESG Rating from MSCI MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.63 From HK$7.43, Keeps at Buy MT
Nomura Adjusts Sinobiopharma's Price Target to HK$7.43 From HK$7.78, Keeps at Buy MT
UBS Adjusts Sino Biopharmaceutical's Price Target to HK$7.5 From HK$8, Keeps at Buy MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$7.78 From HK$8.19, Keeps at Buy MT
Nomura Adjust Sino Biopharma’s Price Target to HK$8.19 From HK$8.53, Keeps at Buy MT
UBS Adjusts Sino Biopharmaceutical's Price Target to HK$8 From HK$11.6, Keeps at Buy MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.53 From HK$9.38, Keeps at Buy MT
SINO BIOPHARMACEUTICAL : Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$9.3 From HK$8.97, Keeps at Buy MT
Market Chatter: Hong Kong's Vaccination Rate Plunges Amid Fears of COVID-19 Jab Complications MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
2.63 CNY
Average target price
4.256 CNY
Spread / Average Target
+61.82%
High Price Target
8.46 CNY
Spread / Highest target
+221.66%
Low Price Target
2.781 CNY
Spread / Lowest Target
+5.74%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Sino Biopharmaceutical Limited

Nomura
UBS

Ratings for Sino Biopharmaceutical Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 1177 Stock
  4. Consensus Sino Biopharmaceutical Limited